Search Results - "Bucci, Maxime"
-
1
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Published in Blood (19-05-2016)“…Acute myeloid leukemia (AML) with t(8;21) or inv(16) have been recognized as unique entities within AML and are usually reported together as core binding…”
Get full text
Journal Article -
2
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Published in BMC bioinformatics (28-10-2022)“…Internal tandem duplications in the FLT3 gene, termed FLT3-ITDs, are useful molecular markers in acute myeloid leukemia (AML) for patient risk stratification…”
Get full text
Journal Article -
3
Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
Published in Haematologica (Roma) (01-05-2018)“…Assessment of minimal residual disease has emerged as a powerful prognostic factor in acute myeloid leukemia. In this study, we investigated the potential of…”
Get full text
Journal Article -
4
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Published in BMC bioinformatics (09-12-2022)Get full text
Journal Article -
5
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Published in Blood cancer journal (New York) (13-06-2024)“…The evaluation of measurable residual disease (MRD) in acute myeloid leukemia (AML) using comprehensive mutation analysis by next-generation sequencing (NGS)…”
Get full text
Journal Article -
6
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
Published in Blood cancer journal (New York) (23-09-2022)Get full text
Journal Article -
7
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
Published in HemaSphere (01-01-2018)“…Supplemental Digital Content is available in the text Despite major treatment improvements over the past decades, pediatric acute myeloid leukemia (AML) is…”
Get full text
Journal Article -
8
-
9
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Published in BMC bioinformatics (28-10-2022)“…Abstract Background Internal tandem duplications in the FLT3 gene, termed FLT3 -ITDs, are useful molecular markers in acute myeloid leukemia (AML) for patient…”
Get full text
Journal Article -
10
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Published in Cancers (21-07-2020)“…Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring…”
Get full text
Journal Article -
11
Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group
Published in Blood (08-12-2017)“…Introduction: Despite major treatment improvements over the past decades, pediatric acute myeloid leukemia (AML) is still a life-threatening malignancy with…”
Get full text
Journal Article -
12
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21)
Published in Leukemia & lymphoma (02-01-2016)Get full text
Journal Article